Add to MyYahoo RSS

Myriad Genetics News

News on Myriad Genetics (Ticker: MYGN) continually updated from thousands of sources around the net.

28 min ago |

The USPTO Issues Guidelines for Subject Matter Eligibility Analysis:...

On March 4th, 2014, the United States Patent and Trademark Office issued a guidance advising examiners and the public of the factors for determining whether an invention satisfies the provisions of 35 U.S.C. A 101, as applied to patent eligibility in view of the U.S. Supreme Court's decisions in Molecular Pathology v.


Related Topix: Patent / Trademark Law, Law, USPTO, Inventions, Science / Technology, Biotech, Medicine, Healthcare Industry

4 hrs ago | The Washington Post

Gene Tests to Match Patients to Therapy to Get FDA Oversight

Commonly used tests to predict disease or match a cancer patient with the drug most likely to work will be more strictly regulated under a U.S. Food and Drug Administration proposal issued today.


Related Topix: Healthcare Law, Law, Food and Drug Administration, Genetics, Medicine, Biotech, Healthcare Industry, Biology, Science, Myriad Pharmaceuticals

8 hrs ago |

FDA To Regulate Thousands Of Cancer, Genetic, And Other Diagnostics

The Food and Drug Administration unveiled plans to regulate thousands of diagnostic tests, including many coming from the exploding field of genetic research, to which it has until now turned a blind eye.


Related Topix: Healthcare Law, Law, Food and Drug Administration, Genetics, Medicine, Biotech, Healthcare Industry, Business News

Wed Jul 30, 2014


Myriad Genetics to Announce Financial Results for the Fiscal Fourth...

Myriad Genetics, Inc. today announced that it will issue financial results for the fiscal fourth quarter and full year 2014 as well as provide financial guidance for fiscal year 2015 following the close of market on Tuesday, August 12, 2014.


Related Topix: Biotech, Medicine, Healthcare Industry, Genetics, Biology, Science, Rules-Based Medicine, Myriad Pharmaceuticals

Wed Jul 23, 2014

North County Public Radio

Biotech firm pulls out of Saranac Lake

The Village of Saranac Lake's plan to grow a cluster of biotechnology companies suffered a setback Monday.


Related Topix: Saranac Lake, NY, Biotech, Science / Technology, Medicine, Healthcare Industry, Lake Placid, NY, Myriad Pharmaceuticals, Lake-Clear, NY

Tue Jul 15, 2014

Insider Selling: Peter D. Meldrum Sells 24,000 Shares of Myriad Genetics Stock

Myriad Genetics Insider Peter D. Meldrum sold 24,000 shares of the company's stock on the open market in a transaction that occurred on Monday, July 14th.


Related Topix: Biotech, Medicine, Healthcare Industry, Genetics, Rules-Based Medicine, Myriad Pharmaceuticals

Thu Jul 10, 2014

Utah Business

The Genetic Information Age: How Utah Fits In

It's no surprise to many Utahns that family history is a major area of interest to residents across the state, but hand in hand with that history comes the much more technical field of genomics - an industry that's also growing rapidly locally.


Related Topix: Utah, Utah Government, Genetics, Medicine, Ancestry, Biotech, Healthcare Industry, University of Utah

Tue Jul 08, 2014


Biotech reels over patent ruling

Guidelines that forbid patents on a wide array of natural products, phenomena and principles have many in the biotechnology and pharmaceutical industries worried about the future of their business.


Related Topix: Biotech, Science / Technology, US News, US Supreme Court, Prometheus Laboratories, Medicine, Healthcare Industry, Rules-Based Medicine, Myriad Pharmaceuticals

Thu Jul 03, 2014

Mother Jones

scalia dunce cap

The decision in Hobby Lobby wasn't the first case in which the court or one of its justices flubbed the facts.


Related Topix: US News, Samuel Alito, Clarence Thomas, Genetics, Biotech, Medicine, Biology, Science, Healthcare Industry

Wed Jul 02, 2014

The Motley Fool

3 Stocks Even Volatility-Loving Nasdaq Investors Hate

Overall, the basis for the rally continues to be intact. The latest unemployment report signaled that the jobs market is continuing to improve, while manufacturing and factory order readings have regularly been exceeding Wall Street's consensus.


Related Topix: Biotech, Healthcare Industry


Ashburn Jobs